omega-n-methylarginine has been researched along with Fabry Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altarescu, G; Bryant, M; Campia, U; Goldstein, S; Moore, DF; Panza, JA; Pursley, R; Schiffmann, R | 1 |
1 other study(ies) available for omega-n-methylarginine and Fabry Disease
Article | Year |
---|---|
Enhanced endothelium-dependent vasodilation in Fabry disease.
Topics: Acetylcholine; Adult; Endothelium, Vascular; Enzyme Inhibitors; Fabry Disease; Female; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vasodilation; Vasodilator Agents | 2001 |